Clinical Trial Update: A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 1/2 safety and dose-finding study of plasmin (human) administered into the middle cerebral artery for ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Plasmin (Human) (plasmin)

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Acute Ischemic Stroke | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-10-21